Table 7.
Dose group | Mean change | 95% CI | P-value |
---|---|---|---|
Galcanezumab 1 mg–placebo | −4.301 | −13.394, 4.791 | 0.3445 |
Galcanezumab 5 mg–placebo | −2.051 | −10.605, 6.502 | 0.6303 |
Galcanezumab 25 mg–placebo | −1.605 | −10.718, 7.508 | 0.7235 |
Galcanezumab 75 mg–placebo | −0.807 | −8.979, 7.366 | 0.8428 |
Galcanezumab 200 mg–placebo | 1.301 | −7.274, 9.875 | 0.7606 |
Galcanezumab 600 mg–placebo | −0.375 | −8.531, 7.781 | 0.9264 |
AIx@HR75, augmentation index at heart rate equal to 75; CI, confidence interval.